Large-scale production of hiPSCs in automated bioreactors to produce wholly-cellular bioinks for tissue engineering

Wednesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST

Sponsor

Large-scale production of hiPSCs in automated bioreactors to produce wholly-cellular bioinks for tissue engineering

Culturing human induced pluripotent stem cells (hiPSCs) suitable for bioprinting applications requires billions of cells, which can differentiate into the desired cell types for tissue engineering. It is challenging to select optimal, reproducible, and scalable process conditions, and culture media, for generating high-yield, functional hiPSCs.

In this webinar, Mark Skylar-Scott, Ph.D., Assistant Professor of Bioengineering at Stanford, and Debbie L. Ho, Basic Life Science Researcher at Stanford, showcase an optimized culture-to-3D bioprinting pipeline for billion cell-scale tissue engineering.

Watch now to:

Learn more about how bioprinting can increase the availability of organs
Explore alternatives to using 2-D flask cultures to generate required cell quantities
Understand how a DoE approach can create efficiencies in your culture process
Learn strategies to maintain hiPSC pluripotency at various bioreactor scales